Explore 3 Stock Ideas & Industry Insights Download Free Report

Translational Development Acquisition Corp. Ordinary Shares

Company price
10.865 USD 0.00 ( 0.05%)
Last update at 2026-11-06T21:00:00Z
VOLUME
9073
Market Cap
210.46M
P/E
41.92

Momentum Score

…

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
10.85
Low
10.88
High
52 Week Price Range
10.34
Low
10.95
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Translational Development Acquisition Corp. is a Nasdaq-listed special purpose acquisition company with limited operating history whose principal activity is sourcing and completing a business combination. Long-term prospects hinge on the performance of any merged target; investors may find appeal in pre-merger exposure to emerging healthcare or biotech assets and potential upside from a successful combination.
Key risks are deal execution and dilution typical of SPACs, clinical and regulatory uncertainty if the target is life-sciences, financing and market-timing uncertainty, and possible liquidation if no qualifying merger occurs.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
10.86
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.00
ROE
-
Net Debt
0.17M
ROCE
-0.52%
Diluted EPS TTM
0.26

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Income before tax 6.36M -0.07M -0.49M -0.07M
Net income 6.36M -0.07M -0.49M -0.07M
Selling general administrative 0.94M 9125.38M 0.49M 0.07M
Gross profit - 744.92M - -
Ebit - - -0.49M -0.07M
Ebitda -0.94M -0.07M -0.49M -
Depreciation and amortization - - - 0.07M
Operating income -0.94M -0.20M -0.49M -0.07M
Other operating expenses 0.94M 0.20M 0.49M 0.07M
Interest expense - 508.56M - -
Total revenue 0.00M 0.00M 0.00M -
Total operating expenses 0.94M 0.20M 0.49M 0.07M
Cost of revenue - 320.87M - -
Total other income expense net 7.31M 0.13M -0.49M -
Net income from continuing ops 6.36M - -0.49M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total assets 181.70M 175.00M 0.00M 0.44M
Intangible assets - 12569165.00M - -
Other current assets 0.01M 0.21M - 0.05M
Total liab 6.58M 6.25M 0.51M 0.46M
Total stockholder equity 175.12M 168.75M -0.51M -0.02M
Other current liab 0.18M -6110776.81M 0.16M 0.40M
Common stock 181.66M 18327.00M 0.00M 0.00M
Capital stock 181.66M 174.35M 0.00M 0.00M
Retained earnings -6.54M -5.60M -0.53M -0.05M
Good will - 9061675.00M - -
Cash 0.03M 0.44M 0.00M 0.00M
Total current liabilities 0.54M 0.21M 0.51M 0.46M
Net debt 0.17M -0.44M 0.35M 0.26M
Short term debt 0.20M 6110777.00M 0.35M 0.26M
Short long term debt 0.20M - 0.35M 0.26M
Short long term debt total 0.20M 6110777.00M 0.35M 0.26M
Other stockholder equity - -35032.65M 0.02M 0.02M
Total current assets 0.04M 0.65M 0.00M 0.05M
Accounts payable 0.16M 0.02M 0.00M -
Accumulated other comprehensive income - 16880.00M - -
Non currrent assets other 181.66M -21630840.00M - 0.38M
Non current assets total 181.66M 174.35M 0.00M 0.38M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Investments - -174.22M 0.00M -
Total cashflows from investing activities - -174.22M - -
Net borrowings 0.20M -0.39M 0.00M -
Total cash from financing activities 0.20M 175.51M 0.00M 0.10M
Net income 6.36M -0.07M -0.49M -0.00M
Change in cash -0.41M 0.44M -0.00M 0.00M
Begin period cash flow 0.44M 0.00M 0.00M -
End period cash flow 0.03M 0.44M 0.00M 0.00M
Total cash from operating activities -0.61M -0.85M -0.00M -0.10M
Issuance of capital stock 0.00M 169.05M 0.00M -
Other cashflows from investing activities - -174.22M - -
Dividends paid 7.31M 0.13M - -
Other cashflows from financing activities 7.31M 6.98M - 0.00M
Capital expenditures 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.34M -0.66M 0.00M -0.00M
Other non cash items -7.31M -0.12M 0.48M -0.10M
Free cash flow -0.61M -0.85M -0.00M -0.00M

Peer Comparison*

Sector: Financial Services Industry: Shell Companies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
TDAC
Translational Development Acquisition Corp. Ordinary Shares
0.00
0.05%
10.87 41.92 - - 1.40
CLUS
CLUS
-
-%
200.00 - - 0.09 0.92
SGDH
Sgd Holdings Ltd
-0.89
88.82%
0.11 - - 59741.55 0.56
LION
Lionsgate Studios Holding Corp.
1.66
13.22%
14.22 - 23.31 1.13 1.35
QKIE
QKIE
-
-%
1.88 - - 470.20 -

Profile*

Translational Development Acquisition Corp. Ordinary Shares

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

52 E. 83rd Street, New York, NY, United States, 10028

917 979 3072

Name Title Year Born
Mr. Michael M. B. Hoffman J.D. Chairman of the Board & CEO 1950
Mr. Avi C. Das Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…